Advanced in Bronchiectasis

Sivagurunathan Sutharsan

Essen, NW, DE 
Advanced in Bronchiectasis
Essen, NW, DE 
OverviewLocationsClinical Research

Overview

Sivagurunathan Sutharsan practices in Essen, Germany. Sutharsan is rated as an Advanced expert by MediFind in the treatment of Bronchiectasis. Their top areas of expertise are Cystic Fibrosis, Bronchiectasis, Pseudomonas Stutzeri Infections, and Situs Inversus.

Their clinical research consists of co-authoring 67 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles and participated in 1 clinical trial in the study of Bronchiectasis.

Locations

Essen, NW, Germany
Other Locations
Duisburg, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Corona-Virus-Disease 2019 (Covid-19) Antibody Responses in Cystic Fibrosis
Corona-Virus-Disease 2019 (Covid-19) Antibody Responses in Cystic Fibrosis
Enrollment Status: Active_not_recruiting
Publish Date: February 26, 2024
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Lenabasum
Study Phase: Phase 2
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
Enrollment Status: Completed
Publish Date: September 04, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

67 Total Publications

Advancements in monitoring paranasal sinuses among people with cystic fibrosis using photon-counting CT.
Advancements in monitoring paranasal sinuses among people with cystic fibrosis using photon-counting CT.
Journal: Acta radiologica (Stockholm, Sweden : 1987)
Published: November 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sutharsan's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile